Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 9, 2012, Pages 1385-1393

  Asao, Rin ^a   Asanuma, Katsuhiko ^a   Kodama, Fumiko ^a   Akiba Takagi, Miyuki ^a   Nagai Hosoe, Yoshiko ^a   Seki, Takuto ^a   Takeda, Yukihiko ^a   Ohsawa, Isao ^a   Mano, Satoshi ^a,b   Matsuoka, Kiyoshi ^b   Kurosawa, Hiroyuki ^c   Ogasawara, Shinya ^c   Hirayama, Yoshiaki ^c   Sekine, Sakari ^c   Horikoshi, Satoshi ^a   Hara, Masanori ^d   Tomino, Yasuhiko ^a,b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c DENKA COMPANY LIMITED   (Japan)

^d Yoshida Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PODOCALYXIN;

ADULT; ARTICLE; CELL COUNT; FEMALE; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PODOCYTE; PROTEIN URINE LEVEL; URINARY EXCRETION;

ADULT; BIOLOGICAL MARKERS; BIOPSY; CREATININE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS, IGA; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; JAPAN; MALE; PODOCYTES; PREDICTIVE VALUE OF TESTS; PROTEINURIA; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SIALOGLYCOPROTEINS; URINE; YOUNG ADULT;

EID: 84866104898     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08110811     Document Type: Article

References (38)

1. KrizW, Gretz N, Lemley KV: Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int 54: 687-697, 1998
2. Mundel P, Shankland SJ: Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005-3015, 2002
3. Asanuma K, Yanagida-Asanuma E, Takagi M, Kodama F, Tomino Y: The role of podocytes in proteinuria. Nephrology (Carlton) 12 [Suppl 3]: S15-S20, 2007
4. Hara M, Yanagihara T, Kihara I: Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein-Henoch purpura nephritis. Clin J Am Soc Nephrol 2: 231-238, 2007
5. Hara M, Yanagihara T, Takada T, Itoh M, Matsuno M, Yamamoto T, Kihara I: Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol 18: 35-41, 1998
6. Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, Floege J: Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 16: 1733-1741, 2005
7. Nielsen JS, McNagny KM: The role of podocalyxin in health and disease. J Am Soc Nephrol 20: 1669-1676, 2009
8. Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, Kajita T: Apical cell membranes are shed into urine from injured podocytes: Anovel phenomenon of podocyte injury. J AmSoc Nephrol 16: 408-416, 2005
9. Hara M, Yanagihara T, Hirayama Y, Ogasawara S, Kurosawa H, Sekine S, Kihara I: Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. Hum Pathol 41: 1265-1275, 2010
10. Habara P, Marecková H, Sopková Z, Malícková K, Zivorová D, Zima T, Tesar V: A novel method for the estimation of podocyte injury: Podocalyxin-positive elements in urine. Folia Biol (Praha) 54: 162-167, 2008
11. Tomino Y: Pathogenesis of IgA nephropathy. Contrib Nephrol 157: 1-7, 2007
12. Lemley KV, Lafayette RA, Safai M, DerbyG, Blouch K, Squarer A, Myers BD: Podocytopenia and disease severity in IgA nephropathy. Kidney Int 61: 1475-1485, 2002
13. Xu L, Yang HC, Hao CM, Lin ST, Gu Y, Ma J: Podocyte number predicts progression of proteinuria in IgA nephropathy. Mod Pathol 23: 1241-1250, 2010
14. Hishiki T, Shirato I, Takahashi Y, Funabiki K, Horikoshi S, Tomino Y: Podocyte injury predicts prognosis in patients with iga nephropathy using a small amount of renal biopsy tissue. Kidney Blood Press Res 24: 99-104, 2001
15. Shigematsu H: Histological grading and staging of IgA nephropathy. Pathol Int 47: 194-202, 1997
16. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'AgatiV, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, HerzenbergAM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H;Working Group of the International IgA Nephropathy Network and the Renal Pathology Society: The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification. Kidney Int 76: 534-545, 2009
17. Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'AmicoG, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, HerzenbergAM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, WalkerPD, WangH, Weening JJ, Yoshikawa N, Zhang H;Working Group of the International IgA Nephropathy Network and the Renal Pathology Society: The Oxford classification of IgA nephropathy: Pathology definitions, correlations, and reproducibility. Kidney Int 76: 546-556, 2009
18. Tomino Y, Sakai H; Special Study Group (IgA Nephropathy) on Progressive Glomerular Disease: Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin Exp Nephrol 7: 93-97, 2003
19. Kershaw DB, Beck SG, Wharram BL, Wiggins JE, Goyal M, Thomas PE, Wiggins RC: Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin. J Biol Chem272: 15708-15714, 1997
20. TsutsumiH, Flanagan TD, Ogra PL: Monoclonal antibodies to the large glycoproteins of respiratory syncytial virus: Possible evidence for several functional antigenic sites. JGen Virol 68: 2161-2167, 1987
21. Kanno K, Kawachi H, Uchida Y, Hara M, Shimizu F, Uchiyama M: Urinary sediment podocalyxin in children with glomerular diseases. Nephron Clin Pract 95: c91-c99, 2003
22. KerjaschkiD, PoczewskiH, DekanG, Horvat R, Balzar E, KraftN, Atkins RC: Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells. J Clin Invest 78: 1142-1149, 1986
23. Matsuo S, Imai E, HorioM, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992, 2009
24. Hara M, Yanagihara T, Kihara I: Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 89: 342-347, 2001
25. Lydia A, Asanuma K, Nonaka K, Takagi M, Jeong KH, Kodama F, Asao R, Asanuma E, Prodjosudjadi W, Tomino Y: Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis. Am J Nephrol 35: 58-68, 2012
26. Efron B: The Jackknife, the Bootstrap, and Other Resampling Plans. CBMS-NSF Monographs, 38. Philadelphia, PA, Society of Industrial and Applied Mathematics, 1982
27. Efron B, Tibshirani RJ: An Introduction to the Bootstrap, Boca Raton, FL, Chapman & Hall, 1993
28. Achenbach J, Mengel M, Tossidou I, Peters I, Park JK, Haubitz M, Ehrich JH, Haller H, Schiffer M: Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. Nephrol Dial Transplant 23: 3138-3145, 2008
29. Schwartz MM, Lewis EJ: Focal segmental glomerular sclerosis: The cellular lesion. Kidney Int 28: 968-974, 1985
30. Hill GS, Karoui KE, Karras A, Mandet C, Duong Van Huyen JP, NochyD, Bruneval P: Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies. Kidney Int 79: 635-642, 2011
31. El Karoui K, Hill GS, Karras A, Moulonguet L, Caudwell V, Loupy A, Bruneval P, Jacquot C, Nochy D: Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int 79: 643-654, 2011
32. Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, Ponticelli C, Locatelli F: Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial. J Am Soc Nephrol 15: 157-163, 2004
33. Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C, Locatelli F: Corticosteroids in IgA nephropathy: A randomised controlled trial. Lancet 353: 883-887, 1999
34. Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA: Immunosuppressive treatments for immunoglobulin A nephropathy: Ameta-analysis of randomized controlled trials. Nephrology (Carlton) 9: 177-185, 2004
35. Barratt J, Feehally J: Treatment of IgA nephropathy. Kidney Int 69: 1934-1938, 2006
36. Shoji T, Nakanishi I, Suzuki A, Hayashi T, TogawaM, Okada N, Imai E, Hori M, Tsubakihara Y: Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy. Am J Kidney Dis 35: 194-201, 2000
37. Shankland SJ: The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006
38. Asanuma K, Akiba-Takagi M, Kodama F, Asao R, Nagai Y, Lydia A, Fukuda H, Tanaka E, Shibata T, Takahara H, Hidaka T, Asanuma E, Kominami E, Ueno T, Tomino Y: Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy. Am J Nephrol 33: 537-549, 2011